Literature DB >> 965386

Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins.

S Strickland, W H Beers.   

Abstract

A quantitative method is described for measuring the amount of plasminogen activator produced by rat ovarian granulosa cells following exposure to hormones in vivo or in vitro. The results confirm the previously reported observation (Beers, W. H., Strickland, S., and Reich, E. (1975) Cell 6, (387-394) that granulosa cells in vivo produce increasing amounts of plasminogen activator as the time of ovulation approaches and that the enzyme is produced only be cells obtained from follicles destined to ovulate. Inactive cells can be stimulated in vitro by gonadotropins to produce plasminogen activator. This response is time- and dose-dependent, and results in an increase of intracellular and extracellular enzyme. Studies of the specificity of this response indicate that preparations of follicle-stimulating hormone are much more effective than corresponding preparations of luteinizing hormone. The effect of other pituitary hormones is also presented. Molecules other than gonadotropins are also capable of stimulating the cells to produce the enzyme. Prostaglandins E1 and E2 and analogues of cAMP effectively stimulated the cells to produce plasminogen activator, cGMP and its analogues and prostaglandins F1a and F2a were without effect as were the six steroids studied. The inactive compounds also did not inhibit the response of the cells to gonadotropins. The granulosa cell plasminogen activator has been analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and has an apparent molecular weight of 75,000. By this and other criteria, the granulosa cell enzyme is similar to one of the species of plasminogen activators obtained from cultures of simian virus 40-transformed rat embryo fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 965386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

Authors:  S C Seifert; T D Gelehrter
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

2.  Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development.

Authors:  Aditi S Ambekar; Dhanashree S Kelkar; Sneha M Pinto; Rakesh Sharma; Indira Hinduja; Kusum Zaveri; Akhilesh Pandey; T S Keshava Prasad; Harsha Gowda; Srabani Mukherjee
Journal:  J Clin Endocrinol Metab       Date:  2014-11-13       Impact factor: 5.958

3.  Complement, complement activation and anaphylatoxins in human ovarian follicular fluid.

Authors:  R Perricone; C de Carolis; C Moretti; E Santuari; G de Sanctis; L Fontana
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 4.  [The enzymatic linkage of fibrinogenesis and fibrinolysis (author's transl)].

Authors:  R E Zimmermann; J Lubinus
Journal:  Klin Wochenschr       Date:  1978-08-15

5.  Migration of Schwann cells and wrapping of neurites in vitro: a function of protease activity (plasmin) in the growth medium.

Authors:  N Kalderon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation.

Authors:  J M Edelberg; M Weissler; S V Pizzo
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

7.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

8.  Effects of interleukin-1, tumor necrosis factor -beta, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells.

Authors:  A C Kohl; D N Tatakis; C Hansen; R Dziak
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

9.  Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle.

Authors:  Nune Markosyan; Diane M Duffy
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

10.  Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.

Authors:  R L Silverstein; L L Leung; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.